IRADIMED CORPORATION Debt Securities, Trading, Unrealized Gain
IRADIMED CORPORATION (IRMD) reported Debt Securities, Trading, Unrealized Gain of $67.50 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2021-03-05
- IRADIMED CORPORATION debt securities, trading, unrealized gain for the quarter ending 2020-06-30 was $15.16K, a 33.80% decline year-over-year.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for the quarter ending 2020-03-31 was $52.34K, a 480.30% increase year-over-year.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for the quarter ending 2019-12-31 was -$522.00, a 156.01% decline year-over-year.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for the quarter ending 2019-09-30 was $7.06K, a 496.20% increase year-over-year.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for fiscal 2019 was $38.46K, a 1679.00% increase from fiscal 2018.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for fiscal 2018 was $2.16K, a 48.80% increase from fiscal 2017.
- IRADIMED CORPORATION debt securities, trading, unrealized gain for fiscal 2017 was $1.45K.
| Period end | Debt Securities, Trading, Unrealized Gain 3 month | Debt Securities, Trading, Unrealized Gain 6 month | Debt Securities, Trading, Unrealized Gain 9 month | Debt Securities, Trading, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2020-06-30 | $15.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $67.50K 10-Q · filed 2020-08-06 | $66.98K derived: sum of 3 quarters · filed 2021-03-05 | $74.04K derived: sum of 4 quarters · filed 2021-03-05 |
| 2020-03-31 | $52.34K 10-Q · filed 2020-05-07 | $51.81K derived: sum of 2 quarters · filed 2021-03-05 | $58.87K derived: sum of 3 quarters · filed 2021-03-05 | $81.78K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-12-31 | -$522.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $6.54K derived: sum of 2 quarters · filed 2021-03-05 | $29.44K derived: sum of 3 quarters · filed 2021-03-05 | $38.46K 10-K · filed 2021-03-05 |
| 2019-09-30 | $7.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $29.96K derived: sum of 2 quarters · filed 2019-11-07 | $38.98K 10-Q · filed 2019-11-07 | $39.92K derived: sum of 4 quarters · filed 2020-03-06 |
| 2019-06-30 | $22.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $31.93K 10-Q · filed 2019-08-07 | $32.86K derived: sum of 3 quarters · filed 2020-03-06 | $34.04K derived: sum of 4 quarters · filed 2020-03-06 |
| 2019-03-31 | $9.02K 10-Q · filed 2019-05-08 | $9.95K derived: sum of 2 quarters · filed 2020-03-06 | $11.13K derived: sum of 3 quarters · filed 2020-03-06 | |
| 2018-12-31 | $932.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $2.12K derived: sum of 2 quarters · filed 2020-03-06 | $2.16K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $1.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.23K 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $46.00 10-Q · filed 2018-08-08 | |||
| 2017-12-31 | $1.45K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |